The new COX-2 inhibitors. Celecoxib and rofecoxib.
Takanishi
G C
GC
D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D017277:Drug Approval; D004347:Drug Interactions; D006801:Humans; D007783:Lactones / Q000008:administration & dosage / Q000494:pharmacology*; D011720:Pyrazoles; D013449:Sulfonamides / Q000008:administration & dosage / Q000494:pharmacology*; D013450:Sulfones; D014481:United States
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib